rotation.to
Following this device: dark.
Free account
rotation.to
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

The company

Focus Universal Inc.

FCUV · Nasdaq

Health CareLife-science toolsNot moving yet

FCUV stood above a rising 150-day average in 0 of the last 52 weekly readings. It is 46.1% below that average now. Life Science Tools & Research Services: 52% of its 79 stocks in an uptrend (+4 points in four weeks); Health Care: 25% (−11 points in four weeks).

Statistics

Rotation
Not moving yet
Weeks in an uptrend
out for 52
Industry in uptrend
52% +4 in 4 wk
Insider buys, 12 months
$0
Insider sales, 12 months
$0
Officials’ trades on record
0
Institutions holding
6 (-3)

In the rotation

Each square a week: lit when it closed above a rising 150-day average. 0 of 52 weeks.

17 Apr – 16 Oct
26%41%57%Apr 26Jun 26Jul 26Sep 26Oct 26

Life-science tools: About half its stocks are in an uptrend and the share has been climbing. Health Care: A minority of its stocks are in an uptrend and the share has fallen sharply over four weeks.

Money in and out

1 Nov 2024 – 1 Oct 2026
$0$24KNov 24May 25Nov 25Apr 26Oct 26

Open-market buys above the line and sales below, in dollars.

Congress and officials

No member of Congress or official has disclosed a trade in it.

Insiders

Buy orders, 12 months0
Sale orders, 12 months0
Buyers · sellers0 · 0

No open-market buy or sale by its insiders on record.

Lines filed since 2 January 2026, newest first; every insider’s older lines are on their own page.

Institutions

Holders6-3 on the quarter
New · exited2 · 5
Reported value$127K

Quarter to 30 Jun 2026, against 31 Mar 2026; newest filing 31 Aug 2026.

ManagerSharesChange
JANE STREET GROUP, LLCnew · filed 14 Aug 202620,269$77K+20,269
CITADEL ADVISORS LLCnew · filed 14 Aug 202611,539$44K+11,539
Tower Research Capital LLC (TRC)reduced · filed 11 Aug 2026843$3,203-149−15.0%
VANGUARD CAPITAL MANAGEMENT LLCreduced · filed 13 Aug 2026697$2,649-2,094−75.0%
BNP PARIBAS FINANCIAL MARKETSreduced · filed 13 Aug 20263$11-18−85.7%
GROUP ONE TRADING LLCreduced · filed 14 Aug 20262$8-7−77.8%
31 Mar 2025 – 30 Jun 2026
6911Mar 25Jun 25Dec 25Mar 26Jun 26

News

No headline names it lately.

Everyone who traded it

Edward Shihai Lee Company insiderDirector, 10% owner · last 17 Nov 20252 · 0
Desheng Wang Company insiderCEO and Director · last 15 Aug 20258 · 6
Sheri Lofgren Company insiderDirector · last 7 Sep 20220 · 1
Michael Ross Pope Company insiderDirector · last 2 Sep 20220 · 5
Jennifer Lingjie Gu Company insiderDirector, 10% owner · last 29 Dec 20210 · 0
Duncan Lee Company insiderChief Financial Officer · last 29 Jun 20181 · 0

Same industry

OABI OmniAbLeading+65%
TXG 10x GenomicsLeading+60%
AVTR AvantorLeading+47%
ILMN IlluminaLeading+44%
RVTY RevvityLeading+37%
MASS 908 DevicesLeading+31%

Distance from each stock’s own 150-day average.

Government contracts

No federal award is tied to it.

From its SEC filings

Profit per saleFY 2025 · to 31 Dec 2025-13.8%
Return on capital employedFY 2025 · to 31 Dec 2025-57.4%
Interest coverFY 2025 · to 31 Dec 2025-69.88×
Research spendFY 2025 · to 31 Dec 2025361%
Share count trendFY 2025 · to 25 Mar 202612.0%
Cash and equivalentsFY 2025 · to 31 Dec 2025$7.9M
Free cash flowFY 2025 · to 31 Dec 2025−$5.1M

Analyst forecasts

No analyst forecasts yet.